Detailed Mechanism Funding and Narrative

Years of mechanism: 2014 2015 2016 2017 2018 2019

Details for Mechanism ID: 17497
Country/Region: Zambia
Year: 2018
Main Partner: University of Maryland
Main Partner Program: NA
Organizational Type: University
Funding Agency: HHS/CDC
Total Funding: $14,984,205 Additional Pipeline Funding: N/A

NOTE: PEPFAR no longer creates activity narratives for each mechanism. In their place, PEPFAR has begun releasing mechanism specific targets that reveal the achievements and programs that are expected of the funding. If available for this mechanism, these targets are presented below.

Mechanism Allocation by Budget Code for Selected Year
Care: Adult Care and Support (HBHC) $400,000
Care: TB/HIV (HVTB) $500,000
Care: Pediatric Care and Support (PDCS) $1,000,000
Testing: HIV Testing and Counseling (HVCT) $556,348
Sexual Prevention: Other Sexual Prevention (HVOP) $639,790
Biomedical Prevention: Prevention of Mother to Child Transmission (MTCT) $1,450,000
Treatment: Adult Treatment (HTXS) $8,945,560
Treatment: Pediatric Treatment (PDTX) $1,492,507
Mechanism Target Information

Since COP2014, PEPFAR no longer produces narratives for every mechanism it funds. However, PEPFAR has now included performance targets or indicator information for each mechanism based on the Monitoring, Evaluation, and Reporting (MER) system. The MER guidance is available on PEPFAR's website https://www.pepfar.gov/reports/guidance/. Note that COP years 2014-2015 were under a previous version of the MER system and the indicators and definitions may have changed as of the new 2.0 guidance.

MER Indicator MER description Target Fiscal Year Target
HTS_SELF 2019 47,392
HTS_SELF 10-14, Female, Directly-Assisted 2019 459
HTS_SELF 10-14, Female, Unassisted 2019 918
HTS_SELF 10-14, Male, Directly-Assisted 2019 459
HTS_SELF 10-14, Male, Unassisted 2019 918
HTS_SELF 15-19, Female, Directly-Assisted 2019 1,378
HTS_SELF 15-19, Female, Unassisted 2019 1,378
HTS_SELF 15-19, Male, Directly-Assisted 2019 918
HTS_SELF 15-19, Male, Unassisted 2019 918
HTS_SELF 20-24, Female, Directly-Assisted 2019 1,836
HTS_SELF 20-24, Female, Unassisted 2019 1,836
HTS_SELF 20-24, Male, Directly-Assisted 2019 1,836
HTS_SELF 20-24, Male, Unassisted 2019 1,836
HTS_SELF 25-29, Female, Directly-Assisted 2019 1,836
HTS_SELF 25-29, Female, Unassisted 2019 1,836
HTS_SELF 25-29, Male, Directly-Assisted 2019 1,836
HTS_SELF 25-29, Male, Unassisted 2019 2,036
HTS_SELF 30-34, Female, Directly-Assisted 2019 1,836
HTS_SELF 30-34, Female, Unassisted 2019 2,036
HTS_SELF 30-34, Male, Directly-Assisted 2019 1,836
HTS_SELF 30-34, Male, Unassisted 2019 2,036
HTS_SELF 35-39, Female, Directly-Assisted 2019 1,836
HTS_SELF 35-39, Female, Unassisted 2019 2,036
HTS_SELF 35-39, Male, Directly-Assisted 2019 1,836
HTS_SELF 35-39, Male, Unassisted 2019 2,036
HTS_SELF 40-49, Female, Directly-Assisted 2019 1,836
HTS_SELF 40-49, Female, Unassisted 2019 1,836
HTS_SELF 40-49, Male, Directly-Assisted 2019 1,836
HTS_SELF 40-49, Male, Unassisted 2019 1,836
HTS_SELF 50+, Female, Directly-Assisted 2019 459
HTS_SELF 50+, Female, Unassisted 2019 458
HTS_SELF 50+, Male, Directly-Assisted 2019 459
HTS_SELF 50+, Male, Unassisted 2019 475
HTS_SELF Directly-Assisted 2019 22,967
HTS_SELF FSW, Directly-Assisted 2019 13,778
HTS_SELF FSW, Unassisted 2019 15,910
HTS_SELF MSM, Directly-Assisted 2019 6,888
HTS_SELF MSM, Unassisted 2019 8,828
HTS_SELF Unassisted 2019 24,425
HTS_SELF Unassisted - Other 2019 6,106
HTS_SELF Unassisted - Self 2019 12,213
HTS_SELF Unassisted - Sex Partner 2019 6,106
HTS_TST <5, Unknown Sex, Negative 2019 272
HTS_TST 1-9, Unknown Sex, Negative 2019 217
HTS_TST 10-14, Female, Negative 2019 32
HTS_TST 10-14, Female, Negative 2019 14
HTS_TST 10-14, Male, Negative 2019 16
HTS_TST 10-14, Male, Negative 2019 11
HTS_TST 15-19, Female, Negative 2019 698
HTS_TST 15-19, Female, Negative 2019 400
HTS_TST 15-19, Male, Negative 2019 189
HTS_TST 15-19, Male, Negative 2019 81
HTS_TST 20-24, Female, Negative 2019 623
HTS_TST 20-24, Female, Negative 2019 274
HTS_TST 20-24, Male, Negative 2019 374
HTS_TST 20-24, Male, Negative 2019 146
HTS_TST 25-29, Female, Negative 2019 355
HTS_TST 25-29, Female, Negative 2019 709
HTS_TST 25-29, Female, Negative 2019 441
HTS_TST 25-29, Female, Negative 2019 82
HTS_TST 25-29, Female, Negative 2019 187
HTS_TST 25-29, Female, Negative 2019 5,116
HTS_TST 25-29, Female, Negative 2019 58
HTS_TST 25-29, Female, Negative 2019 8,815
HTS_TST 25-29, Female, Negative 2019 148
HTS_TST 25-29, Female, Negative 2019 45
HTS_TST 25-29, Female, Negative 2019 5,093
HTS_TST 25-29, Female, Negative 2019 234
HTS_TST 25-29, Male, Negative 2019 388
HTS_TST 25-29, Male, Negative 2019 728
HTS_TST 25-29, Male, Negative 2019 463
HTS_TST 25-29, Male, Negative 2019 85
HTS_TST 25-29, Male, Negative 2019 188
HTS_TST 25-29, Male, Negative 2019 5,126
HTS_TST 25-29, Male, Negative 2019 64
HTS_TST 25-29, Male, Negative 2019 155
HTS_TST 25-29, Male, Negative 2019 49
HTS_TST 25-29, Male, Negative 2019 5,301
HTS_TST 25-29, Male, Negative 2019 234
HTS_TST 30-34, Female, Negative 2019 355
HTS_TST 30-34, Female, Negative 2019 709
HTS_TST 30-34, Female, Negative 2019 441
HTS_TST 30-34, Female, Negative 2019 82
HTS_TST 30-34, Female, Negative 2019 187
HTS_TST 30-34, Female, Negative 2019 5,116
HTS_TST 30-34, Female, Negative 2019 58
HTS_TST 30-34, Female, Negative 2019 6,608
HTS_TST 30-34, Female, Negative 2019 148
HTS_TST 30-34, Female, Negative 2019 45
HTS_TST 30-34, Female, Negative 2019 5,193
HTS_TST 30-34, Female, Negative 2019 234
HTS_TST 30-34, Male, Negative 2019 388
HTS_TST 30-34, Male, Negative 2019 728
HTS_TST 30-34, Male, Negative 2019 463
HTS_TST 30-34, Male, Negative 2019 85
HTS_TST 30-34, Male, Negative 2019 188
HTS_TST 30-34, Male, Negative 2019 5,126
HTS_TST 30-34, Male, Negative 2019 64
HTS_TST 30-34, Male, Negative 2019 155
HTS_TST 30-34, Male, Negative 2019 49
HTS_TST 30-34, Male, Negative 2019 5,301
HTS_TST 30-34, Male, Negative 2019 234
HTS_TST 35-39, Female, Negative 2019 355
HTS_TST 35-39, Female, Negative 2019 709
HTS_TST 35-39, Female, Negative 2019 441
HTS_TST 35-39, Female, Negative 2019 82
HTS_TST 35-39, Female, Negative 2019 187
HTS_TST 35-39, Female, Negative 2019 5,116
HTS_TST 35-39, Female, Negative 2019 58
HTS_TST 35-39, Female, Negative 2019 4,405
HTS_TST 35-39, Female, Negative 2019 148
HTS_TST 35-39, Female, Negative 2019 45
HTS_TST 35-39, Female, Negative 2019 5,093
HTS_TST 35-39, Female, Negative 2019 234
HTS_TST 35-39, Male, Negative 2019 388
HTS_TST 35-39, Male, Negative 2019 728
HTS_TST 35-39, Male, Negative 2019 463
HTS_TST 35-39, Male, Negative 2019 85
HTS_TST 35-39, Male, Negative 2019 188
HTS_TST 35-39, Male, Negative 2019 5,126
HTS_TST 35-39, Male, Negative 2019 64
HTS_TST 35-39, Male, Negative 2019 155
HTS_TST 35-39, Male, Negative 2019 49
HTS_TST 35-39, Male, Negative 2019 5,401
HTS_TST 35-39, Male, Negative 2019 234
HTS_TST 40-49, Female, Negative 2019 355
HTS_TST 40-49, Female, Negative 2019 709
HTS_TST 40-49, Female, Negative 2019 441
HTS_TST 40-49, Female, Negative 2019 82
HTS_TST 40-49, Female, Negative 2019 187
HTS_TST 40-49, Female, Negative 2019 5,116
HTS_TST 40-49, Female, Negative 2019 58
HTS_TST 40-49, Female, Negative 2019 2,203
HTS_TST 40-49, Female, Negative 2019 148
HTS_TST 40-49, Female, Negative 2019 45
HTS_TST 40-49, Female, Negative 2019 5,093
HTS_TST 40-49, Female, Negative 2019 234
HTS_TST 40-49, Male, Negative 2019 388
HTS_TST 40-49, Male, Negative 2019 728
HTS_TST 40-49, Male, Negative 2019 463
HTS_TST 40-49, Male, Negative 2019 85
HTS_TST 40-49, Male, Negative 2019 188
HTS_TST 40-49, Male, Negative 2019 5,126
HTS_TST 40-49, Male, Negative 2019 64
HTS_TST 40-49, Male, Negative 2019 155
HTS_TST 40-49, Male, Negative 2019 49
HTS_TST 40-49, Male, Negative 2019 5,301
HTS_TST 40-49, Male, Negative 2019 234
HTS_TST 50+, Female, Negative 2019 494
HTS_TST 50+, Female, Negative 2019 203
HTS_TST 50+, Male, Negative 2019 496
HTS_TST 50+, Male, Negative 2019 195
HTS_TST Number of individuals who received T&C services for HIV and received their test results during the past 12 months 2019 315,052
HTS_TST Service Delivery Point (Community) Index Mod: 1-9, Negative 2019 480
HTS_TST Service Delivery Point (Community) Index Mod: 10-14, Female, Negative 2019 11
HTS_TST Service Delivery Point (Community) Index Mod: 10-14, Male, Negative 2019 37
HTS_TST Service Delivery Point (Community) Index Mod: 15-19, Female, Negative 2019 384
HTS_TST Service Delivery Point (Community) Index Mod: 15-19, Male, Negative 2019 128
HTS_TST Service Delivery Point (Community) Index Mod: 20-24, Female, Negative 2019 342
HTS_TST Service Delivery Point (Community) Index Mod: 20-24, Male, Negative 2019 223
HTS_TST Service Delivery Point (Community) Index Mod: 50+, Female, Negative 2019 247
HTS_TST Service Delivery Point (Community) Index Mod: 50+, Male, Negative 2019 192
HTS_TST Service Delivery Point (Community) Mobile Testing: 1-9, Negative 2019 266
HTS_TST Service Delivery Point (Community) Mobile Testing: 10-14, Female, Negative 2019 133
HTS_TST Service Delivery Point (Community) Mobile Testing: 10-14, Male, Negative 2019 31
HTS_TST Service Delivery Point (Community) Mobile Testing: 15-19, Female, Negative 2019 171
HTS_TST Service Delivery Point (Community) Mobile Testing: 15-19, Male, Negative 2019 44
HTS_TST Service Delivery Point (Community) Mobile Testing: 20-24, Female, Negative 2019 140
HTS_TST Service Delivery Point (Community) Mobile Testing: 20-24, Male, Negative 2019 83
HTS_TST Service Delivery Point (Community) Mobile Testing: 50+, Female, Negative 2019 109
HTS_TST Service Delivery Point (Community) Mobile Testing: 50+, Male, Negative 2019 111
HTS_TST Service Delivery Point (Community) Other: 15-19, Female, Negative 2019 116
HTS_TST Service Delivery Point (Community) Other: 15-19, Male, Negative 2019 31
HTS_TST Service Delivery Point (Community) Other: 20-24, Female, Negative 2019 107
HTS_TST Service Delivery Point (Community) Other: 20-24, Male, Negative 2019 61
HTS_TST Service Delivery Point (Community) Other: 50+, Female, Negative 2019 83
HTS_TST Service Delivery Point (Community) Other: 50+, Male, Negative 2019 84
HTS_TST Service Delivery Point (Community) VCT Mod: 1-9, Negative 2019 172
HTS_TST Service Delivery Point (Community) VCT Mod: 10-14, Female, Negative 2019 29
HTS_TST Service Delivery Point (Community) VCT Mod: 10-14, Male, Negative 2019 14
HTS_TST Service Delivery Point (Community) VCT Mod: 15-19, Female, Negative 2019 508
HTS_TST Service Delivery Point (Community) VCT Mod: 15-19, Male, Negative 2019 156
HTS_TST Service Delivery Point (Community) VCT Mod: 20-24, Female, Negative 2019 469
HTS_TST Service Delivery Point (Community) VCT Mod: 20-24, Male, Negative 2019 234
HTS_TST Service Delivery Point (Community) VCT Mod: 50+, Female, Negative 2019 351
HTS_TST Service Delivery Point (Community) VCT Mod: 50+, Male, Negative 2019 313
HTS_TST Service Delivery Point (Facility) ANC: 10-14, Negative 2019 224
HTS_TST Service Delivery Point (Facility) ANC: 15-19, Negative 2019 9,209
HTS_TST Service Delivery Point (Facility) ANC: 20-24, Negative 2019 12,726
HTS_TST Service Delivery Point (Facility) ANC: 50+, Negative 2019 760
HTS_TST Service Delivery Point (Facility) Index: 1-9, Negative 2019 1,561
HTS_TST Service Delivery Point (Facility) Index: 10-14, Female, Negative 2019 252
HTS_TST Service Delivery Point (Facility) Index: 10-14, Male, Negative 2019 140
HTS_TST Service Delivery Point (Facility) Index: 15-19, Female, Negative 2019 1,387
HTS_TST Service Delivery Point (Facility) Index: 15-19, Male, Negative 2019 540
HTS_TST Service Delivery Point (Facility) Index: 20-24, Female, Negative 2019 1,434
HTS_TST Service Delivery Point (Facility) Index: 20-24, Male, Negative 2019 818
HTS_TST Service Delivery Point (Facility) Index: 50+, Female, Negative 2019 1,275
HTS_TST Service Delivery Point (Facility) Index: 50+, Male, Negative 2019 800
HTS_TST Service Delivery Point (Facility) Inpatient: 1-9, Negative 2019 2,673
HTS_TST Service Delivery Point (Facility) Inpatient: 10-14, Female, Negative 2019 435
HTS_TST Service Delivery Point (Facility) Inpatient: 10-14, Male, Negative 2019 234
HTS_TST Service Delivery Point (Facility) Inpatient: 15-19, Female, Negative 2019 902
HTS_TST Service Delivery Point (Facility) Inpatient: 15-19, Male, Negative 2019 238
HTS_TST Service Delivery Point (Facility) Inpatient: 20-24, Female, Negative 2019 791
HTS_TST Service Delivery Point (Facility) Inpatient: 20-24, Male, Negative 2019 483
HTS_TST Service Delivery Point (Facility) Inpatient: 50+, Female, Negative 2019 629
HTS_TST Service Delivery Point (Facility) Inpatient: 50+, Male, Negative 2019 600
HTS_TST Service Delivery Point (Facility) Other PITC: 1-9, Negative 2019 16,460
HTS_TST Service Delivery Point (Facility) Other PITC: 10-14, Female, Negative 2019 3,606
HTS_TST Service Delivery Point (Facility) Other PITC: 10-14, Male, Negative 2019 1,957
HTS_TST Service Delivery Point (Facility) Other PITC: 15-19, Female, Negative 2019 11,117
HTS_TST Service Delivery Point (Facility) Other PITC: 15-19, Male, Negative 2019 2,808
HTS_TST Service Delivery Point (Facility) Other PITC: 20-24, Female, Negative 2019 9,426
HTS_TST Service Delivery Point (Facility) Other PITC: 20-24, Male, Negative 2019 5,177
HTS_TST Service Delivery Point (Facility) Other PITC: 50+, Female, Negative 2019 6,669
HTS_TST Service Delivery Point (Facility) Other PITC: 50+, Male, Negative 2019 6,333
HTS_TST Service Delivery Point (Facility) Pediatric : <5 Negative 2019 5,576
HTS_TST Service Delivery Point (Facility) TB: 15-19, Female, Negative 2019 53
HTS_TST Service Delivery Point (Facility) TB: 15-19, Male, Negative 2019 24
HTS_TST Service Delivery Point (Facility) TB: 20-24, Female, Negative 2019 52
HTS_TST Service Delivery Point (Facility) TB: 20-24, Male, Negative 2019 53
HTS_TST Service Delivery Point (Facility) TB: 50+, Female, Negative 2019 61
HTS_TST Service Delivery Point (Facility) TB: 50+, Male, Negative 2019 126
HTS_TST Service Delivery Point (Facility) VCT: 1-9, Negative 2019 6,675
HTS_TST Service Delivery Point (Facility) VCT: 10-14, Female, Negative 2019 1,081
HTS_TST Service Delivery Point (Facility) VCT: 10-14, Male, Negative 2019 603
HTS_TST Service Delivery Point (Facility) VCT: 15-19, Female, Negative 2019 10,389
HTS_TST Service Delivery Point (Facility) VCT: 15-19, Male, Negative 2019 2,797
HTS_TST Service Delivery Point (Facility) VCT: 20-24, Female, Negative 2019 8,929
HTS_TST Service Delivery Point (Facility) VCT: 20-24, Male, Negative 2019 5,359
HTS_TST Service Delivery Point (Facility) VCT: 50+, Female, Negative 2019 6,896
HTS_TST Service Delivery Point (Facility) VCT: 50+, Male, Negative 2019 6,674
HTS_TST_POS <5, Unknown Sex, Positive 2019 57
HTS_TST_POS 1-9, Unknown Sex, Positive 2019 2
HTS_TST_POS 10-14, Female, Positive 2019 3
HTS_TST_POS 10-14, Male, Positive 2019 1
HTS_TST_POS 15-19, Female, Positive 2019 15
HTS_TST_POS 15-19, Female, Positive 2019 17
HTS_TST_POS 15-19, Male, Positive 2019 2
HTS_TST_POS 15-19, Male, Positive 2019 3
HTS_TST_POS 20-24, Female, Positive 2019 12
HTS_TST_POS 20-24, Female, Positive 2019 17
HTS_TST_POS 20-24, Male, Positive 2019 1
HTS_TST_POS 20-24, Male, Positive 2019 24
HTS_TST_POS 25-29, Female, Positive 2019 6
HTS_TST_POS 25-29, Female, Positive 2019 268
HTS_TST_POS 25-29, Female, Positive 2019 50
HTS_TST_POS 25-29, Female, Positive 2019 10
HTS_TST_POS 25-29, Female, Positive 2019 83
HTS_TST_POS 25-29, Female, Positive 2019 410
HTS_TST_POS 25-29, Female, Positive 2019 7
HTS_TST_POS 25-29, Female, Positive 2019 371
HTS_TST_POS 25-29, Female, Positive 2019 17
HTS_TST_POS 25-29, Female, Positive 2019 28
HTS_TST_POS 25-29, Female, Positive 2019 387
HTS_TST_POS 25-29, Female, Positive 2019 17
HTS_TST_POS 25-29, Male, Positive 2019 5
HTS_TST_POS 25-29, Male, Positive 2019 408
HTS_TST_POS 25-29, Male, Positive 2019 62
HTS_TST_POS 25-29, Male, Positive 2019 13
HTS_TST_POS 25-29, Male, Positive 2019 95
HTS_TST_POS 25-29, Male, Positive 2019 783
HTS_TST_POS 25-29, Male, Positive 2019 4
HTS_TST_POS 25-29, Male, Positive 2019 21
HTS_TST_POS 25-29, Male, Positive 2019 34
HTS_TST_POS 25-29, Male, Positive 2019 551
HTS_TST_POS 25-29, Male, Positive 2019 34
HTS_TST_POS 30-34, Female, Positive 2019 6
HTS_TST_POS 30-34, Female, Positive 2019 268
HTS_TST_POS 30-34, Female, Positive 2019 50
HTS_TST_POS 30-34, Female, Positive 2019 14
HTS_TST_POS 30-34, Female, Positive 2019 83
HTS_TST_POS 30-34, Female, Positive 2019 410
HTS_TST_POS 30-34, Female, Positive 2019 7
HTS_TST_POS 30-34, Female, Positive 2019 278
HTS_TST_POS 30-34, Female, Positive 2019 17
HTS_TST_POS 30-34, Female, Positive 2019 28
HTS_TST_POS 30-34, Female, Positive 2019 387
HTS_TST_POS 30-34, Female, Positive 2019 17
HTS_TST_POS 30-34, Male, Positive 2019 5
HTS_TST_POS 30-34, Male, Positive 2019 408
HTS_TST_POS 30-34, Male, Positive 2019 62
HTS_TST_POS 30-34, Male, Positive 2019 13
HTS_TST_POS 30-34, Male, Positive 2019 95
HTS_TST_POS 30-34, Male, Positive 2019 783
HTS_TST_POS 30-34, Male, Positive 2019 4
HTS_TST_POS 30-34, Male, Positive 2019 21
HTS_TST_POS 30-34, Male, Positive 2019 34
HTS_TST_POS 30-34, Male, Positive 2019 551
HTS_TST_POS 30-34, Male, Positive 2019 24
HTS_TST_POS 35-39, Female, Positive 2019 6
HTS_TST_POS 35-39, Female, Positive 2019 268
HTS_TST_POS 35-39, Female, Positive 2019 50
HTS_TST_POS 35-39, Female, Positive 2019 10
HTS_TST_POS 35-39, Female, Positive 2019 83
HTS_TST_POS 35-39, Female, Positive 2019 410
HTS_TST_POS 35-39, Female, Positive 2019 7
HTS_TST_POS 35-39, Female, Positive 2019 178
HTS_TST_POS 35-39, Female, Positive 2019 17
HTS_TST_POS 35-39, Female, Positive 2019 28
HTS_TST_POS 35-39, Female, Positive 2019 387
HTS_TST_POS 35-39, Female, Positive 2019 17
HTS_TST_POS 35-39, Male, Positive 2019 5
HTS_TST_POS 35-39, Male, Positive 2019 418
HTS_TST_POS 35-39, Male, Positive 2019 62
HTS_TST_POS 35-39, Male, Positive 2019 13
HTS_TST_POS 35-39, Male, Positive 2019 110
HTS_TST_POS 35-39, Male, Positive 2019 783
HTS_TST_POS 35-39, Male, Positive 2019 4
HTS_TST_POS 35-39, Male, Positive 2019 21
HTS_TST_POS 35-39, Male, Positive 2019 34
HTS_TST_POS 35-39, Male, Positive 2019 551
HTS_TST_POS 35-39, Male, Positive 2019 27
HTS_TST_POS 40-49, Female, Positive 2019 6
HTS_TST_POS 40-49, Female, Positive 2019 268
HTS_TST_POS 40-49, Female, Positive 2019 50
HTS_TST_POS 40-49, Female, Positive 2019 10
HTS_TST_POS 40-49, Female, Positive 2019 83
HTS_TST_POS 40-49, Female, Positive 2019 410
HTS_TST_POS 40-49, Female, Positive 2019 7
HTS_TST_POS 40-49, Female, Positive 2019 94
HTS_TST_POS 40-49, Female, Positive 2019 17
HTS_TST_POS 40-49, Female, Positive 2019 28
HTS_TST_POS 40-49, Female, Positive 2019 387
HTS_TST_POS 40-49, Female, Positive 2019 17
HTS_TST_POS 40-49, Male, Positive 2019 5
HTS_TST_POS 40-49, Male, Positive 2019 428
HTS_TST_POS 40-49, Male, Positive 2019 62
HTS_TST_POS 40-49, Male, Positive 2019 13
HTS_TST_POS 40-49, Male, Positive 2019 95
HTS_TST_POS 40-49, Male, Positive 2019 783
HTS_TST_POS 40-49, Male, Positive 2019 4
HTS_TST_POS 40-49, Male, Positive 2019 21
HTS_TST_POS 40-49, Male, Positive 2019 34
HTS_TST_POS 40-49, Male, Positive 2019 551
HTS_TST_POS 40-49, Male, Positive 2019 24
HTS_TST_POS 50+, Female, Positive 2019 1
HTS_TST_POS 50+, Female, Positive 2019 25
HTS_TST_POS 50+, Male, Positive 2019 6
HTS_TST_POS 50+, Male, Positive 2019 38
HTS_TST_POS Service Delivery Point (Community) Index Mod: 1-9, Positive 2019 30
HTS_TST_POS Service Delivery Point (Community) Index Mod: 10-14, Female, Positive 2019 1
HTS_TST_POS Service Delivery Point (Community) Index Mod: 10-14, Male, Positive 2019 3
HTS_TST_POS Service Delivery Point (Community) Index Mod: 15-19, Female, Positive 2019 69
HTS_TST_POS Service Delivery Point (Community) Index Mod: 15-19, Male, Positive 2019 52
HTS_TST_POS Service Delivery Point (Community) Index Mod: 20-24, Female, Positive 2019 86
HTS_TST_POS Service Delivery Point (Community) Index Mod: 20-24, Male, Positive 2019 76
HTS_TST_POS Service Delivery Point (Community) Index Mod: 50+, Female, Positive 2019 112
HTS_TST_POS Service Delivery Point (Community) Index Mod: 50+, Male, Positive 2019 158
HTS_TST_POS Service Delivery Point (Community) Mobile Testing: 1-9, Positive 2019 4
HTS_TST_POS Service Delivery Point (Community) Mobile Testing: 10-14, Female, Positive 2019 3
HTS_TST_POS Service Delivery Point (Community) Mobile Testing: 15-19, Female, Positive 2019 6
HTS_TST_POS Service Delivery Point (Community) Mobile Testing: 15-19, Male, Positive 2019 4
HTS_TST_POS Service Delivery Point (Community) Mobile Testing: 20-24, Female, Positive 2019 16
HTS_TST_POS Service Delivery Point (Community) Mobile Testing: 20-24, Male, Positive 2019 18
HTS_TST_POS Service Delivery Point (Community) Mobile Testing: 50+, Female, Positive 2019 13
HTS_TST_POS Service Delivery Point (Community) Mobile Testing: 50+, Male, Positive 2019 13
HTS_TST_POS Service Delivery Point (Community) Other: 15-19, Female, Positive 2019 10
HTS_TST_POS Service Delivery Point (Community) Other: 15-19, Male, Positive 2019 3
HTS_TST_POS Service Delivery Point (Community) Other: 20-24, Female, Positive 2019 4
HTS_TST_POS Service Delivery Point (Community) Other: 20-24, Male, Positive 2019 4
HTS_TST_POS Service Delivery Point (Community) Other: 50+, Female, Positive 2019 4
HTS_TST_POS Service Delivery Point (Community) Other: 50+, Male, Positive 2019 4
HTS_TST_POS Service Delivery Point (Community) VCT Mod: 1-9, Positive 2019 3
HTS_TST_POS Service Delivery Point (Community) VCT Mod: 15-19, Female, Positive 2019 17
HTS_TST_POS Service Delivery Point (Community) VCT Mod: 15-19, Male, Positive 2019 10
HTS_TST_POS Service Delivery Point (Community) VCT Mod: 20-24, Female, Positive 2019 40
HTS_TST_POS Service Delivery Point (Community) VCT Mod: 20-24, Male, Positive 2019 17
HTS_TST_POS Service Delivery Point (Community) VCT Mod: 50+, Female, Positive 2019 24
HTS_TST_POS Service Delivery Point (Community) VCT Mod: 50+, Male, Positive 2019 24
HTS_TST_POS Service Delivery Point (Facility) ANC: 10-14, Positive 2019 4
HTS_TST_POS Service Delivery Point (Facility) ANC: 15-19, Positive 2019 378
HTS_TST_POS Service Delivery Point (Facility) ANC: 20-24, Positive 2019 525
HTS_TST_POS Service Delivery Point (Facility) ANC: 50+, Positive 2019 31
HTS_TST_POS Service Delivery Point (Facility) Index: 1-9, Positive 2019 100
HTS_TST_POS Service Delivery Point (Facility) Index: 10-14, Female, Positive 2019 15
HTS_TST_POS Service Delivery Point (Facility) Index: 10-14, Male, Positive 2019 8
HTS_TST_POS Service Delivery Point (Facility) Index: 15-19, Female, Positive 2019 119
HTS_TST_POS Service Delivery Point (Facility) Index: 15-19, Male, Positive 2019 95
HTS_TST_POS Service Delivery Point (Facility) Index: 20-24, Female, Positive 2019 142
HTS_TST_POS Service Delivery Point (Facility) Index: 20-24, Male, Positive 2019 255
HTS_TST_POS Service Delivery Point (Facility) Index: 50+, Female, Positive 2019 374
HTS_TST_POS Service Delivery Point (Facility) Index: 50+, Male, Positive 2019 653
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 1-9, Positive 2019 46
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 10-14, Female, Positive 2019 10
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 10-14, Male, Positive 2019 2
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 15-19, Female, Positive 2019 52
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 15-19, Male, Positive 2019 22
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 20-24, Female, Positive 2019 55
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 20-24, Male, Positive 2019 19
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 50+, Female, Positive 2019 38
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 50+, Male, Positive 2019 74
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 1-9, Positive 2019 401
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 10-14, Female, Positive 2019 29
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 10-14, Male, Positive 2019 16
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 15-19, Female, Positive 2019 183
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 15-19, Male, Positive 2019 105
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 20-24, Female, Positive 2019 242
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 20-24, Male, Positive 2019 388
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 50+, Female, Positive 2019 551
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 50+, Male, Positive 2019 941
HTS_TST_POS Service Delivery Point (Facility) Pediatric : <5 Positive 2019 114
HTS_TST_POS Service Delivery Point (Facility) TB: 15-19, Female, Positive 2019 13
HTS_TST_POS Service Delivery Point (Facility) TB: 15-19, Male, Positive 2019 15
HTS_TST_POS Service Delivery Point (Facility) TB: 20-24, Female, Positive 2019 22
HTS_TST_POS Service Delivery Point (Facility) TB: 20-24, Male, Positive 2019 24
HTS_TST_POS Service Delivery Point (Facility) TB: 50+, Female, Positive 2019 42
HTS_TST_POS Service Delivery Point (Facility) TB: 50+, Male, Positive 2019 118
HTS_TST_POS Service Delivery Point (Facility) VCT: 1-9, Positive 2019 152
HTS_TST_POS Service Delivery Point (Facility) VCT: 10-14, Female, Positive 2019 32
HTS_TST_POS Service Delivery Point (Facility) VCT: 10-14, Male, Positive 2019 5
HTS_TST_POS Service Delivery Point (Facility) VCT: 15-19, Female, Positive 2019 301
HTS_TST_POS Service Delivery Point (Facility) VCT: 15-19, Male, Positive 2019 100
HTS_TST_POS Service Delivery Point (Facility) VCT: 20-24, Female, Positive 2019 519
HTS_TST_POS Service Delivery Point (Facility) VCT: 20-24, Male, Positive 2019 284
HTS_TST_POS Service Delivery Point (Facility) VCT: 50+, Female, Positive 2019 561
HTS_TST_POS Service Delivery Point (Facility) VCT: 50+, Male, Positive 2019 876
KP_PREV By key population type: Men who have sex with men who are NOT sex workers (Numerator: Number of key populations reached with individual and/or small group level HIV preventive interventions that are based on evidence and/or meet the minimum standards required) 2019 100
KP_PREV By key population type: People in prisons and enclosed settings (Numerator: Number of key populations reached with individual and/or small group level HIV preventive interventions that are based on evidence and/or meet the minimum standards required) 2019 621
KP_PREV Number of key populations reached with individual and/or small group level HIV preventive interventions that are based on evidence and/or meet the minimum standards required 2019 721
PMTCT_ART Already on ART at beginning of current pregnancy 2019 2,943
PMTCT_ART New on ART 2019 2,818
PMTCT_ART Number of HIV-positive pregnant women who received ART to reduce risk of mother-to-child-transmission (MTCT) during pregnancy 2019 5,761
PMTCT_ART Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2019 50,218
PMTCT_EID By infants who received a virologic test within 2 months of birth 2019 4,603
PMTCT_EID By infants who received their first virologic HIV test between 2 and 12 months of age 2019 1,158
PMTCT_EID Number of infants who had a virologic HIV test within 12 months of birth during the reporting period 2019 5,761
PMTCT_EID Sum of Infant Age disaggregates 2019 5,761
PMTCT_STAT 25-29, Female 2019 14,351
PMTCT_STAT 25-29, Female, Known at Entry Positive 2019 795
PMTCT_STAT 25-29, Female, Newly Identified Negative 2019 13,034
PMTCT_STAT 25-29, Female, Newly Identified Positive 2019 522
PMTCT_STAT 30-34, Female 2019 10,898
PMTCT_STAT 30-34, Female, Known at Entry Positive 2019 795
PMTCT_STAT 30-34, Female, Newly Identified Negative 2019 9,731
PMTCT_STAT 30-34, Female, Newly Identified Positive 2019 372
PMTCT_STAT 35-39, Female 2019 7,893
PMTCT_STAT 35-39, Female, Known at Entry Positive 2019 634
PMTCT_STAT 35-39, Female, Newly Identified Negative 2019 6,736
PMTCT_STAT 35-39, Female, Newly Identified Positive 2019 523
PMTCT_STAT 40-49, Female 2019 6,594
PMTCT_STAT 40-49, Female, Known at Entry Positive 2019 124
PMTCT_STAT 40-49, Female, Newly Identified Negative 2019 5,643
PMTCT_STAT 40-49, Female, Newly Identified Positive 2019 827
PMTCT_STAT By Age (Numerator): 15-19 2019 158
PMTCT_STAT By Age (Numerator): 20-24 2019 10,324
PMTCT_STAT By Number of known positives: 15-19 2019 34
PMTCT_STAT By Number of known positives: 20-24 2019 561
PMTCT_STAT By Number of new negative: 15-19 2019 66
PMTCT_STAT By Number of new negative: 20-24 2019 9,247
PMTCT_STAT By Number of new positives: 15-19 2019 58
PMTCT_STAT By Number of new positives: 20-24 2019 516
PMTCT_STAT Number of new ANC and L&D clients 2019 52,750
PMTCT_STAT Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2019 50,218
PMTCT_STAT_den 25-29, Female 2019 10,898
PMTCT_STAT_den 30-34, Female 2019 7,893
PMTCT_STAT_den 35-39, Female 2019 7,893
PMTCT_STAT_den By Age (Denominator): <15-19 2019 10,562
PMTCT_STAT_den By Age (Denominator): 10-14 2019 69
PMTCT_STAT_den By Age (Denominator): 20-24 2019 15,421
PMTCT_STAT_den By Age (Denominator): 50+ 2019 14
PrEP_NEW 25-29, Female 2019 280
PrEP_NEW 25-29, Male 2019 506
PrEP_NEW 30-34, Female 2019 421
PrEP_NEW 30-34, Male 2019 84
PrEP_NEW 35-39, Female 2019 84
PrEP_NEW 35-39, Male 2019 17
PrEP_NEW 40-49, Female 2019 17
PrEP_NEW Female 20-24 2019 280
PrEP_NEW FSW 2019 978
PrEP_NEW MSM 2019 211
PrEP_NEW Number of individuals who have been newly enrolled on oral antiretroviral pre-exposure prophylaxis (PrEP) in the reporting period to prevent HIV infection 2019 1,689
TB_ART Aggregated Age/Sex: Female <15 (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2019 52
TB_ART Aggregated Age/Sex: Female 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2019 623
TB_ART Aggregated Age/Sex: Male <15 (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2019 40
TB_ART Aggregated Age/Sex: Male 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2019 405
TB_ART The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period 2019 1,145
TB_PREV By Age/Sex (Numerator): <15, Female 2019 838
TB_PREV By Age/Sex (Numerator): <15, Male 2019 305
TB_PREV By Age/Sex (Numerator): 15+, Female 2019 10,254
TB_PREV By Age/Sex (Numerator): 15+, Male 2019 10,829
TB_PREV IPT, Life-long ART, New, Positive 2019 22,226
TB_PREV The number of ART patients who completed a course of TB preventive therapy or at least 6 months of Isoniazid Preventive Therapy (IPT) during the reporting period 2019 22,226
TB_PREV The number of ART patients who were newly started on TB preventive therapy (including those who newly started on TB preventive therapy in this reporting period and those who started in the previous reporting period but had not been reported as they did not fulfill the minimum requirements for the previous reporting period) 2019 37,045
TB_PREV_den By Age/Sex (Denominator): <15, Female 2019 935
TB_PREV_den By Age/Sex (Denominator): <15, Male 2019 728
TB_PREV_den By Age/Sex (Denominator): 15+, Female 2019 23,449
TB_PREV_den By Age/Sex (Denominator): 15+, Male 2019 11,933
TB_PREV_den IPT, Life-long ART, New, Positive 2019 37,045
TB_STAT Aggregated Age/Sex: Female <15 (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2019 55
TB_STAT Aggregated Age/Sex: Female 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2019 698
TB_STAT Aggregated Age/Sex: Male <15 (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2019 53
TB_STAT Aggregated Age/Sex: Male 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2019 1,160
TB_STAT Number of registered new and relapsed TB cases with documented HIV status, during the reporting period 2019 1,966
TB_STAT Total number of registered new and relapsed TB cases, during the reporting period 2019 1,966
TB_STAT_den Aggregated Age/Sex: Female <15 (Denominator: Total number of registered new and relapsed TB cases, during the reporting period) 2019 55
TB_STAT_den Aggregated Age/Sex: Female 15+ (Denominator: Total number of registered new and relapsed TB cases, during the reporting period) 2019 698
TB_STAT_den Aggregated Age/Sex: Male <15 (Denominator: Total number of registered new and relapsed TB cases, during the reporting period) 2019 53
TB_STAT_den Aggregated Age/Sex: Male 15+ (Denominator: Total number of registered new and relapsed TB cases, during the reporting period) 2019 1,160
TX_CURR 25-29, Female, Positive 2019 8,559
TX_CURR 25-29, Male, Positive 2019 3,739
TX_CURR 30-34, Female, Positive 2019 10,803
TX_CURR 30-34, Male, Positive 2019 7,360
TX_CURR 35-39, Female, Positive 2019 9,653
TX_CURR 35-39, Male, Positive 2019 8,569
TX_CURR 40-49, Female, Positive 2019 15,245
TX_CURR 40-49, Male, Positive 2019 14,699
TX_CURR Age/Sex: <1 2019 2,815
TX_CURR Age/Sex: <1-9 2019 5,157
TX_CURR Age/Sex: 10-14 Female 2019 2,796
TX_CURR Age/Sex: 10-14 Male 2019 1,034
TX_CURR Age/Sex: 15-19 Female 2019 3,352
TX_CURR Age/Sex: 15-19 Male 2019 3,319
TX_CURR Age/Sex: 20-24 Female 2019 5,515
TX_CURR Age/Sex: 20-24 Male 2019 3,137
TX_CURR Age/Sex: 50+ Female 2019 6,338
TX_CURR Age/Sex: 50+ Male 2019 7,627
TX_CURR Number of adults and children receiving antiretroviral therapy (ART) 2019 119,579
TX_CURR Sum of age/sex disaggregates 2019 6,671
TX_NEW 25-29, Female, Positive 2019 1,994
TX_NEW 25-29, Male, Positive 2019 645
TX_NEW 30-34, Female, Positive 2019 2,461
TX_NEW 30-34, Male, Positive 2019 1,333
TX_NEW 35-39, Female, Positive 2019 2,232
TX_NEW 35-39, Male, Positive 2019 1,561
TX_NEW 40-49, Female, Positive 2019 3,576
TX_NEW 40-49, Male, Positive 2019 2,613
TX_NEW Breastfeeding status 2019 7,005
TX_NEW By Age/Sex: <1 2019 32
TX_NEW By Age/Sex: 1-9 2019 3,011
TX_NEW By Age/Sex: 10-14 Female 2019 497
TX_NEW By Age/Sex: 10-14 Male 2019 179
TX_NEW By Age/Sex: 15-19 Female 2019 759
TX_NEW By Age/Sex: 15-19 Male 2019 388
TX_NEW By Age/Sex: 20-24 Female 2019 1,194
TX_NEW By Age/Sex: 20-24 Male 2019 488
TX_NEW By Age/Sex: 50+ Female 2019 2,097
TX_NEW By Age/Sex: 50+ Male 2019 3,044
TX_NEW FSW 2019 446
TX_NEW MSM 2019 917
TX_NEW Number of adults and children newly enrolled on antiretroviral therapy (ART) 2019 28,104
TX_NEW Pregnancy status 2019 3,971
TX_NEW Sum of Age/Sex disaggregates 2019 8,646
TX_PVLS Number of adult and pediatric ART patients with a viral load result documented in the patient medical record and /or laboratory records in the past 12 months 2019 119,719
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: <15 Female Routine 2019 6,747
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: <15 Male Routine 2019 5,085
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: 15+ Female Routine 2019 59,442
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: 15+ Male Routine 2019 48,445
TX_RET Aggregated Age/Sex: <15 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2019 1,155
TX_RET Aggregated Age/Sex: <15 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2019 870
TX_RET Aggregated Age/Sex: 15+ Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2019 12,535
TX_RET Aggregated Age/Sex: 15+ Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2019 8,358
TX_RET Number of adults and children who are still alive and on treatment at 12 months after initiating ART 2019 22,918
TX_RET Numerator by Status: Breastfeeding 2019 1,255
TX_RET Numerator by Status: Pregnant 2019 4,768
TX_RET Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up 2019 24,197
TX_RET_den Aggregated Age/Sex: <15 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2019 1,229
TX_RET_den Aggregated Age/Sex: <15 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2019 927
TX_RET_den Aggregated Age/Sex: 15+ Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2019 13,202
TX_RET_den Aggregated Age/Sex: 15+ Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2019 8,839
TX_RET_den Denominator by Status: Breastfeeding 2019 1,320
TX_RET_den Denominator by Status: Pregnant 2019 5,022
TX_TB Number of ART patients who were screened for TB at least once during the reporting period 2019 108,945
TX_TB_den Denominator: By Aggregated Age/Sex: <15, Female 2019 4,357
TX_TB_den Denominator: By Aggregated Age/Sex: <15, Male 2019 3,269
TX_TB_den Denominator: By Aggregated Age/Sex:15+, Female 2019 58,829
TX_TB_den Denominator: By Aggregated Age/Sex:15+, Male 2019 42,490
TX_TB_den Denominator: By Diagnostic Test [Subdisagg of Specimen Sent]: Gene Xpert MTB / R if Assay 2019 108,945
TX_TB_den Denominator: Number of ART patients who had a specimen sent for bacteriologic diagnosis of active TB disease 2019 108,945
TX_TB_den Life-long ART, New, TB Screen - Negative, Positive 2019 108,945
Cross Cutting Budget Categories and Known Amounts Total: $3,058,174
Key Populations: Sex Workers $50,000
Implementation of core HIV prevention interventions for SWs consistent with PEPFAR guidance on sexual prevention
Conducting epidemiologic, social science, and operational research among SWs, their partners, and clients
Monitoring and evaluation of SW programs
Key Populations: MSM and TG $30,000
Implementation of core HIV prevention interventions for MSM/TG that are consistent with the current PEPFAR technical guidance
Collection and use of strategic information
Monitoring and evaluation of MSM/TG programs
Condoms: Policy, Tools, and Services $25,000
Human Resources for Health $2,953,174